Furthermore, we observed that cfDNA could promote the proliferation of hormone receptor positive (HR+) breast cancer cells by the activating toll-like receptor 9 (TLR9)-nuclear factor kappa B (NF-κB)-cyclin D1 pathway. This evidence concerns the gene CCND1 and breast cancer.